| ZEALAND PHARMA US, INC. | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid |
| ONE WORLD TECHNOLOGIES, INC. | DLA PIPER LLP (US) | Q3 2026 | Consumer Issues/Safety/Products |
| B. BRAUN MEDICAL INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| ST. JOSEPHS/CANDLER HEALTH SYSTEM, INC. | DLA PIPER LLP (US) | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid |
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | Q3 2026 | Defense, Veterans, Health Issues |
| XEROX HOLDINGS CORPORATION | DLA PIPER LLP (US) | Q3 2026 | Pharmacy |
| BIONJ, INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| AMERIHEALTH CARITAS | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid |
| IQVIA HOLDINGS, INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy |
| CURRAX PHARMACEUTICALS LLC | DLA PIPER LLP (US) | Q2 2026 | Pharmacy |
| INTRA-CELLULAR THERAPIES, INC. | DLA PIPER LLP (US) | Q4 2025 | Health Issues |
| CALIFORNIA APARTMENT ASSOCIATION | DLA PIPER LLP (US) | Q4 2025 | Pharmacy |
| IRHYTHM TECHNOLOGIES, INC. | DLA PIPER LLP (US) | Q3 2025 | Medicare/Medicaid |
| RESMED CORP. | DLA PIPER LLP (US) | Q3 2025 | Health Issues |
| NOVARTIS | DLA PIPER LLP (US) | Q2 2025 | Medical/Disease Research/Clinical Labs, Pharmacy |
| SAMSUNG SDI AMERICA, INC | DLA PIPER LLP (US) | Q1 2025 | Taxation/Internal Revenue Code, Energy/Nuclear, Automotive Industry |
| INDEPENDENCE BLUE CROSS, LLC | DLA PIPER LLP (US) | Q1 2025 | Health Issues |
| BIOHAVEN PHARMACEUTICALS, INC. | DLA PIPER LLP (US) | Q1 2025 | Health Issues |